Comprehensive Blood & Cancer Center
VC Fund
Bakersfield, United States
Comprehensive Blood & Cancer Center is a VC fund in Bakersfield focused on Health Care and Information Technology. Comprehensive Blood & Cancer Center specializes in surgical oncology, hematology, radiation oncology, skin, and dermatology.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Comprehensive Blood & Cancer Center invests in
Stages Comprehensive Blood & Cancer Center invests in
Countries Comprehensive Blood & Cancer Center invests in
Investment Focus
Industry
- Health Care 1 (50%)
- Information Technology 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Akido Labs
|
Akido is a care delivery platform focused on overcoming the complex needs of our most vulnerable populations. We are on a mission to leverage modern technology and proprietary datasets that have historically been locked up in our public health ecosystems in order to radically improve the quality of life and affordability of care for underservedpeople.We are a fast-growing, impact-focused, Y Combinator company being used nationwide to combat the Covid-19 pandemic, homelessness, and other public health crises. Across the country, health systems and government service providers use Akido to launch new technology-powered public health initiatives that improve the health and well-being of the communities they serve. | $60M / Series B / May 15, 2025 | |
|
Akido Labs
|
Akido is a care delivery platform focused on overcoming the complex needs of our most vulnerable populations. We are on a mission to leverage modern technology and proprietary datasets that have historically been locked up in our public health ecosystems in order to radically improve the quality of life and affordability of care for underservedpeople.We are a fast-growing, impact-focused, Y Combinator company being used nationwide to combat the Covid-19 pandemic, homelessness, and other public health crises. Across the country, health systems and government service providers use Akido to launch new technology-powered public health initiatives that improve the health and well-being of the communities they serve. | $11.2M / Series A / Dec 16, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Comprehensive Blood & Cancer Center invest in?
Comprehensive Blood & Cancer Center invests primarily in Health Care and Information Technology startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Comprehensive Blood & Cancer Center last invest?
The most recent investment recorded for Comprehensive Blood & Cancer Center closed in May 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
